Pictor receives $5M in funding for Covid antibody test and human and animal portfolios
Pictor, a global leader in immunodiagnostics, has announced a $5 million funding round to help…
December 6, 2022 - 3 minutes
Immunotherapy
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
Licensing agreement signed for C4XD between C4X Discovery and AstraZeneca
C4X Discovery Holdings plc has signed an exclusive worldwide licensing agreement with AstraZeneca. It is worth…
November 28, 2022 - 3 minutes
Achilles Therapeutics receives US patent for immunotherapies
A U.S. patent has been granted to Achilles Therapeutics plc for the treatment of patients…
November 22, 2022 - 2 minutes
FMRP – the protein behind immunotherapy resistance
Immunotherapy is a cutting-edge approach to treating cancer by turning the patient’s own immune system…
November 21, 2022 - 6 minutes
MIF invests in KAHR to explore lead immunotherapy drug for multiple myeloma
KAHR Medical, a clinical stage biotech company that is developing a treatment for solid tumors…
November 18, 2022 - 3 minutes
NW Bio reports positive top-line results from phase 3 glioblastoma trial
Northwest Biotherapeutics, which is developing DCVax personalized immune therapies for solid tumor cancers, yesterday (November…
November 18, 2022 - 4 minutes
First patient dosed in Nouscom colorectal cancer study
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, says the first patient…
November 15, 2022 - 3 minutes
Nutcracker Therapeutics sees anti-tumor responses of lead mRNA immunotherapy
Nutcracker Therapeutics, Inc. has presented the first set of preclinical data for its lead oncology…
November 14, 2022 - 3 minutes
ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy
ISA Pharmaceuticals B.V, a Netherlands-based clinical stage biotech developing immunotherapies to treat cancers and infectious…
November 8, 2022 - 2 minutes
Creative Medical Technology Holdings announces FDA clearance of diabetes drug
Creative Medical Technology Holdings yesterday (November 3) announced its investigational new drug (IND) application has…
November 4, 2022 - 3 minutes
Reprogramming immune cells can fight melanoma
A new way of reprogramming immune cells to shrink or kill off cancer cells has…
October 31, 2022 - 3 minutes
